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Background: Toxoplasmosis, a zoonotic disease distributed worldwide, is an infection caused by the ubiquitous
obligatory intracellular coccidian protozoan organism, Toxoplasma gondii. It is a major public health concern
because the disease is serious in terms of mortality or physical and /or psychological sequellae in patients with HIV
disease. The aim of the study was to assess the seroprevalence of Toxoplasma gondii IgG and IgM antibodies and
associated risk factors in HIV infected and non-infected individuals attending Felege Hiwot referral hospital, Bahir
Dar, Northwest Ethiopia.
Methods: A cross sectional study was conducted at Felege Hiwot referral hospital, Bahir Dar, Amhara National
Regional State. Venous blood samples were collected from 103 HIV infected pre anti-retroviral therapy patients at
Felege Hiwot referral hospital and 101 HIV negative apparently healthy voluntary blood donors at the blood bank.
Serum samples were analyzed for anti-Toxoplasma gondii IgG and IgM antibodies using a commercially available
ELISA kit. Socio-demographic and associated risk factors for Toxoplasmosis from each individual were also obtained
and the data was analyzed using SPSS version 18.
Results: Of the examined HIV seropositive individuals, 87.4% (90/103) and 10.7% (11/103) were positive for anti-T.
gondii IgG and IgM antibodies, respectively. Multivariate analysis using logistic regression showed that anti-T. gondii
seropositivity was independently significantly associated with undercooked or raw meat consumption (adjusted
OR=5.73, 95% CI=1.35-24.39; P=0.02) and having contact with cat (adjusted OR= 4.29, 95% CI=1.08-16.94; P=0.04) in
HIV positive individuals. In HIV negative apparently healthy blood donors, prevalence of anti-T. gondii antibodies
were 70.29% and 2.97% for IgG and IgM, respectively. Multivariate analysis showed that undercooked or raw meat
consumption (adjusted OR=6.45, 95% CI=2.16-19.28; p=0.001) and sex (OR=6.79, 95% CI=2.14-21.60; p=0.001) were
independently significantly associated with anti-T. gondii IgG seropositivity, with a significantly higher number of
males affected than females.
Conclusion: The present findings showed a high sero-prevalence of anti-T. gondii antibodies in HIV infected
pre-ART and HIV non-infected apparently healthy blood donors in Bahir Dar. Consumption of undercooked or raw
meat might greatly contribute towards acquiring T. gondii infection in HIV infected pre-ART and HIV non-infected
apparently healthy blood donors. It may be appropriate to include routine serological screening test for
determination of anti-T. gondii antibodies in HIV infected pre-ART individuals and HIV negative apparently healthy
blood donors. In addition, health education towards avoiding eating undercooked and raw meat, and avoiding
contact with cats were recommended.
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Toxoplasmosis is a globally distributed zoonosis [1]
caused by the ubiquitous obligatory intracellular coccidian
protozoan organism, Toxoplasma gondii that infects a
wide range of animals, man and birds [2,3]. T. gondii is an
opportunistic parasitic infection in immune compromised
hosts [4,5] and estimates indicate that up to one third of
the world's human population is infected [6]. Prevalence
of the infection varies widely, depending on social and cul-
tural habits, geographic factors, climate, and transmission
route. It has been reported that the prevalence is higher in
warm and humid areas [7]. The parasite causes chronic
infection in adults and is present in an estimated 22.5% of
people older than 12 in the United States [8] and up to
90% of the population in other regions of the world [9].
T. gondii is transmitted to humans by eating raw or
inadequately cooked infected meat [10]; through ingestion
of oocysts that cats have passed in their feces and women
can transmit the infection transplacentally to their
unborn fetus. Other infection pathways are transfusion,
transplantation and direct contamination [11]. In adults,
the incubation period for T. gondii infection ranges from
10 to 23 days [12].
Toxoplasmosis is a major public health concern because
the disease is serious in terms of mortality or physical and
/or psychological sequellae in patients with HIV dis-
ease [13]. In the majority of normal, healthy (immune
competent) subjects, infection is asymptomatic [7,14] and
frequently results in the chronic persistence of cysts within
host tissues; the cysts normally lie dormant, probably for
life [14]. But, in immune compromised states such as in
HIV infections, subjects are at risk of developing acute
toxoplasmosis due to reactivation of the organism if their
CD4+ T-cell count decreases below 200 cells/μL [15,16].
Since the pandemic of HIV infection has spread throughout
the world, toxoplasmosis has been implicated as one of the
most important opportunistic infections in HIV/AIDS
patients [17-19]. Moreover, in up to 10% of HIV infected
immune competent individuals, it causes cervical lymph-
adenopathy or ocular disease [19].
In the immunocompromised patients, diseases due to
T. gondii are generally considered to represent reactivation
of latent infection [20]. Detection and monitoring of
anti-Toxoplasma antibodies are of a great interest in
HIV-infected patients. Ethiopia is one of the high HIV
epidemic countries [21] with approximately 1.5 million
people infected and living with HIV/AIDS. About 5-7% of
patients live in and around Bahir Dar and its neighboring
areas. However, the Toxoplasmosis serologic status and
risk factors of infection among HIV-infected patients and
HIV non-infected apparently healthy individuals remain
unknown. Therefore, this study aimed to determine the
seroprevalence of anti-T. gondii IgG and IgM antibodies in
HIV infected and non-infected individuals and to identifythe possible risk factors associated with toxoplasmosis in
Bahir Dar, northwest Ethiopia.
Methods
Study area and study subjects
A cross sectional study was conducted to determine the
seroprevalence and risk factors of toxoplasmosis in HIV
infected and non-infected individuals at Felege Hiwot
referral hospital, Bahir Dar, Amhara National Regional
State, northwest Ethiopia. Bahir Dar is the capital of
Amhara National Regional state, located approximately
578 km Northwest of Addis Ababa, having a latitude
and longitude of 11°360N 37°230E11.6°N 37.383°E11.6;
37.383 coordinates and an elevation of 1840 meters
above sea level. Based on the 2007 Census conducted by
the Central Statistical Agency of Ethiopia (CSA), this city
has a total human population of 221,991 [22].
The study participants were individuals who visited
the hospital to know their HIV sero-status and to donate
blood for their families. Thus, the study subjects were
HIV sero-positive pre-ART individuals attending the pre-
ART clinic of Felege Hiwot referral hospital (Group1), and
HIV sero-negative apparently healthy adults who came to
the hospital for blood donation (Group 2). The convenient
sampling method was followed.
Inclusion criteria of the study subjects in Group 1 were:
1) HIV sero-positive ART naive individuals attending the
pre-ART clinic for further management; 2) aged 18
years and older; 3) not taking chemoprophylaxis for
toxoplasmosis; and in Group 2 were: 1) voluntary blood
donors (HIV, HCV, HBs Ag and Treponema pallidum sero-
negatives); 2) aged 18–55 years; in both cases individuals
who accepted to participate in the study were considered.
Data collection
Five milliliters of venous blood without anticoagulant
was aseptically collected from 103 HIV positive ART
naive and 101 HIV negative apparently healthy voluntary
blood donors at Felege Hiwot referral hospital pre-ART
and blood bank laboratories, respectively. Collected
blood samples were transported immediately to Bahir Dar
Regional Health Research Laboratory. In the laboratory
serum was separated, labeled and stored at −20°C until use.
Using a pretested questionnaire, data on socio-
demographic characteristics and associated risk factors
were collected from all study participants.
Serological assays
Serum samples were screened for anti-T. gondii IgG and
IgM antibodies by ELISA using "Toxoplasma IgG and
IGM" kit (Human, GmbH.65205 Wiesbaden-Biochemical
Diagnostic, Germany) according to the manufacturers’
instructions. Positive and negative controls were used with
each series of anti T. gondii IgG/IgM test (Human,
Walle et al. Parasites & Vectors 2013, 6:15 Page 3 of 8
http://www.parasitesandvectors.com/content/6/1/15Germany); results were obtained by comparison with a
cut-off value measured at 450nm absorbance.
Ethical approval
Ethical clearance to conduct the study was obtained from
Aklilu Lemma Institute of Pathobiology (ALIPB), Addis
Ababa University (AAU) and Amhara National Regional
State Health Bureau (ANRSHB). The purpose and proce-
dures of the study were explained and a written informed
consent was obtained from all study participants. Study
participants with positive test result for toxoplasmosis
were treated following standard protocols at Felege Hiwot
referral hospital, following the FMOH (Federal Ministry of
Health), guidelines [23].
Statistical analysis
Data was entered into MS Excel, cleaned and analyzed
using SPSS software, with Version 18.0. Pearson Chi-
square, Odds Ratio and 95% confidence interval were
used for group comparison and association of variables.
P values were determined and taken as a level of signifi-
cance when found less than 0.05.
Results
The overall prevalence of anti-T. gondii IgG antibodies in
HIV positives pre-ART individuals and apparently healthy
blood donors were found to be 87.4% (90/103) and 70.29%
(71/101), respectively. The difference between the two
groups in anti-T. gondii IgG seropositivity was statistically
significant (p=0.003). Similarly, the overall anti-T. gondii
IgM seropositivity was 10% (11/103) among HIV infected
Pre ART and 2.97 % (3/101) in HIV non-infected study
participants; the difference was statistically significant
(p=0.02). Overall, the prevalence of anti-T. gondii antibodies
in HIV positives pre-ART individuals was significantly
higher than HIV non-infected apparently healthy blood
donors (Tables 1, 2).
In HIV infected pre-ART individuals studied, where the
majority reported having contact with cats 72/103 (69.9%)
and the habit of eating raw or undercooked meat 86/103
(83.5%), the bivariate analysis showed a significant associ-
ation between these factors and seropositivity to anti-T.
gondii IgG antibodies (Table 1). No significant association
was observed between seropositivity for anti-T. Gondii
IgG antibodies and educational status, eating unwashed
raw vegetables or fruits, residence (urban versus rural
inhabitants). In addition, the prevalence of anti-T. gondii
IgG, among the HIV positive pre-ART individuals was not
statistically influenced by the sex and age categories tested.
In the study there were only three individuals with history
of blood transfusion, and all of them were HIV positive.
In HIV infected pre-ART individuals, no statistically
significant association was detected between anti-T. gon-
dii IgM seropositivity and all the risk factors evaluated.In HIV non-infected apparently healthy voluntary
blood donors, among the demographic and other risk
factors studied, consumption of undercooked or raw
meat and sex of the individual was significantly asso-
ciated with anti-T. gondii IgG seropositivity. The rate of
anti-T. gondii IgG seropositivity was significantly higher
in males than females, and in those eating raw or under-
cooked meat compared to those who did not (Table 2).
As shown in Table 3, multivariate analysis using logis-
tic regression showed that undercooked or raw meat
consumption (adjusted OR=5.73, 95% CI=1.35-24.39,
p=0.02) and having contact with cat (adjusted OR= 4.29,
95% CI=1.08-16.94, p=0.04) were independently asso-
ciated with anti Toxoplasma IgG seropositivity in HIV
infected patients. Whereas in HIV uninfected partici-
pants, undercooked or raw meat consumption (adjusted
OR=6.45, 95% CI=2.16-19.28; p=0.001) and being male
(adjusted OR=6.79, 95% CI=2.14-21.60, p=0.001) were
independently significantly associated with anti-T. gondii
IgG seropositivity (Table 4). In addition, being in the age
group 21–30 was significantly associated with T. gondii
IgG seropositivity compared to the reference age group
18–20 years (adjusted OR 5.58, 95% CI=1.62-19.29,
p=0.01).
Discussion
Toxoplasmosis refers to the disease caused by T. gondii
[24]. In the present study Toxoplasma specific IgG and
IgM antibody levels were analyzed using ELISA, one of
the standard procedures for detection of antibodies [18].
Detection of both IgG and IgM simultaneously helps
establishing exposure to T. gondii and the chronological
status of such exposure. In the present study the preva-
lence rate of anti-T. gondii IgG antibodies in HIV
positive pre-ART individuals was significantly higher
than in HIV negative blood donors (87.4% versus
70.29%, P=0.003). Similar finding of significantly higher
Toxoplasma seropositivity in HIV infected individuals
than in HIV-uninfected people was also demonstrated in
Addis Ababa [25]. The finding of significant difference
between HIV infected and non-infected individuals also
agrees with studies done in Bamako, 60% versus 21%
[26] and in Nigeria 54% versus 37.5% [27]. These differ-
ences might be attributed to the reactivation of latent in-
fection/tissue toxoplasmosis when the host immunity is
compromised (reduced cellular immunity) in HIV patients
[28]. In addition, variability in results can be due to differ-
ences in age among the study groups and differing lifestyles
and geographical conditions. In our case, HIV infected
patients were older compared to the HIV negative counter-
parts (median age 23 versus 34 years, p=0.000).
The overall finding of a high seroprevalence of IgG in
HIV positive pre-ART individuals was comparable with
the study done in Akaki town, suburban of Addis Ababa,
Table 1 Seroprevalence of Toxoplasma infection in HIV infected pre-ART individuals according to socio demographic
and other risk factors
Variable Frequency (%) IgG +ve (%) P value* IgM +ve(%) P value
Age in years 0.45 0.78
18-20 3(2.9) 3(100) 0 (0.0)
21-30 43(41.8) 35 (81.4) 4(9.3)
31-40 31(30.1) 28(90.3) 3(9.7)
41-55 26(25.2) 24(92.3) 4(15.4)
Sex 0.39 0.70
M 43(41. 7) 39 (90.7) 4 (9.3)
F 60 (58.3) 51(85.0) 7 (11.7)
Place of residence 0.29 0.75
Urban 96(93.2) 83(86.5) 10(10.4)
Rural 7(6.8 ) 7(100) 1(14.3)
Education 0.20 0.68
Literate 71(68.9) 64(90.1) 7(9.9)
Illiterate 32(31.1) 26(81.3) 4(12.5)
History of blood transfusion 0.27 0.19
Yes 3(2.9) 2(66.7) 1 (33.3)
No 100(97.1) 88(88.0) 10(10.0)
Contact with cat 0.04 0.83
Yes 72(69.9) 66(91.7) 8(11.1)
No 31(30.1) 24 (77.4) 3(9.7)
Eating undercooked or raw meat 0.02 0.31
Yes 86(83.5) 78(90.7) 8(9.3)
No 17(16.5) 12(70.6) 3(17.7)
Eating unwashed raw vegetables or fruits 0.85 0.82
Yes 50(48.5) 44(88.0) 6(12.0)
No 53(51.5) 46(86.8) 5(9.4)
Total 103(100) 90(87.4) 11 (10.7)
*P values were calculated using Chi square test.
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antibodies using the Sabin-Feldman test and 80%
seroprevalence was reported [29]. Our finding is also
consistent with a Venezuelan study which demonstrated
85% prevalence of anti-T. gondii IgG antibody in the
HIV-positive adult population [15]. However, our result
was much higher than other studies as in Johannesburg
8% [30]. It also differs from a study done in Iran among
HIV/AIDs patients which reported prevalence of 58%
[31]. The observed differences in prevalence of anti-T.
gondii antibodies could be due to differences in geo-
graphical distribution and/ or possible risk factors and
socioeconomic conditions [32] contributing to acquiring
the infection.
In the present study, anti-T. gondii IgM seropositivity
rate was 10.7% in HIV infected pre-ART individuals. A
similar study in India reported 6% anti-Toxoplasma IgM
positivity using double sandwich ELISA [14]. The
consumption of undercooked or raw meat and contactwith cat were found to be risk factors for the presence of
anti-T. gondii IgG in HIV infected pre-ART individuals.
Similar results were demonstrated by studies done in
Nazaret town, Ethiopia [3] and at Lagos University
teaching hospital, Nigeria [27]. On the other hand, no
significant association was identified between the history
of blood transfusion and anti-T. gondii seropositivity. It
is worth mentioning that the number of participants
with a history of blood transfusion was only three and
all of them were HIV positive. Nonetheless, a similar
study in Malaysia has documented the absence of a
significant association between a history of blood
transfusion and T. gondii seropositivity [24]. Beef, lamb
and chicken are eaten in the study area. In the nation
raw meat dishes such as "Kitfo" and "kourt" are most
favored by the society and eaten raw or lightly cooked.
However, HIV positive individuals are advised to eat
cooked meat to minimize persistent immune activation
as a result of tapeworms and or other secondary
Table 3 Multivariate analysis of selected characteristics of
103 HIV infected Pre-ART individuals and their







Literate 1.31 0.35-4.87 0.69
Illiterate 1
Contact with Cat
Yes 4.29 1.08-16.94 0.04
No 1
Eating under cooked or raw meat
Yes 5.73 1.35-24.39 0.02
No 1
a The variables included were those with P≤0.2 obtained in the bivariate analysis.
b Odds ratio adjusted for variables included in the table.
Table 2 Seroprevalence of Toxoplasma infection in HIV non-infected apparently healthy blood donors according to
socio demographic and other risk factors
Variable Frequency (%) IgG +ve(%) P value* IgM +ve(%) P value
Age in years 0.06 0.52
18-20 29 (28.7) 15(51.7) 1(3.5)
21-30 53(52.5) 41(77.4) 1(1. 9)
31-40 9(8.9) 8(88.9) 0 (0.0)
41-55 10(9.9) 7(70.0) 1 (10.0)
Sex 0.001 0.54
M 50(49.5) 44(88.0) 2 (4.0)
F 51(50.5) 27(52.9) 1 (2.0)
Place of residence 0.88 0.25
Urban 67(66.3) 46 (68.7) 1 (1.5)
Rural 34(33.7) 25 (73.5) 2 (5.9)
Education 0.86 0.23
Literate 66(65.4) 46(69.7) 1 (1.5)
Illiterate 35(34.7) 25(71.4) 2(5.7)
History of blood transfusion
Yes 0 0 0(0.0)
No 101(100) 71(70.3) 3(3.0)
Contact with cat 0.81 0.95
Yes 69(68.3) 48(69.6) 2 (2.9)
No 32(31.7) 23(71.9) 1 (3.1)
Eating undercooked or raw meat 0.001 0.17
Yes 63 (62.4) 53 (84.1) 3 (4.8)
No 38 (37.6) 18 (47.4) 0 (0.0)
Eating unwashed raw vegetables or fruits 0.17 0.82
Yes 61(60.4) 46(75.4) 2(3.3)
No 40(39.6) 25(62.5) 1(2.5)
Total 101(100%) 71(70.29%) 3/101(2.97)
*P values were calculated using Chi square test.
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mechanism of CD4 depletion. HIV negative individuals
consume raw and undercooked favorite meat dishes such
as "Kitfo" and "kourt" of the Ethiopians. Pork is not
consumed at all in the study area.
According to the present findings, no statistically sig-
nificant difference was observed among different age
groups and inhabitants of rural and urban areas of HIV
infected and non-infected study participants, and the
associated sero-reactivity of anti-T. gondii antibodies.
The exception to this is the age group 21–30 in the HIV
negatives where individuals are 5.58 times more likely to
be seropositive for anti-T. gondii antibodies. This is in
agreement with previous studies on the prevalence of
anti-T. gondii IgG antibodies from blood donors in
Yucatan [33] and seroprevalence of anti-T. gondii anti-
bodies in a healthy population from Slovakia [7]. The
prevalence of anti-T. gondii IgG and IgM antibodies in
HIV negative blood donors were 70.29% and 2.97%,
Table 4 Multivariate analysis of selected characteristics of
101HIVnegative apparently healthy voluntary blood








Male 6.79 2.14-21.60 0.001
Female 1
Age
18-20 1 1.62-19.29 0.01
21–30 5.58 0.73-104.47 0.09
31–40 8.71 0.31-14.04 0.45
41-55 2.09
Eating under cooked or raw meat
Yes 6.45 2.16-19.28 0.001
No 1
a The variables included were those with P≤0.2 obtained in the bivariate analysis.
b Odds ratio adjusted for variables included in the table.
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comparable to the 2.4% and 1.9% reported from Czech
Republic and Mexico blood donors, respectively [34,35].
The present finding of anti-T. gondii IgG antibodies in
blood donors is consistent with the 75% prevalence
reported from Brazil [36] and 69% from the Southern
Mexican State of Yucatan [33]. Consumption of under-
cooked or raw meat was found to be a risk factor for the
presence of anti-T. gondii IgG in HIV negative individuals.
Undercooked meat consumption has been found to be an
important factor in parasite transmission in several studies
[18,35]. A similar finding was also demonstrated as risk
factor for toxoplasmosis in studies done in Slovakia [7].
Moreover, prevalence of anti-T. gondii IgG from male
healthy blood donors was significantly higher than female
HIV negative blood donors (p=0.001).
In the present study no significant association was
found between the seroprevalence of toxoplasmosis and
different educational status. Similar findings were
recorded between anti Toxoplasma IgG antibodies and
education level [27] and the infection among pregnant
women in Turkey [37].
Generally, IgM antibodies are detectable early after
infection and can persist for prolonged times after infec-
tion. Therefore, the presence of IgM does not necessarily
indicate an acute infection and its presence in subjects
with anti T. gondii IgG antibodies could indicate a
chronic infection [34]. Hence, though we cannot confirm
in this study, the finding of sero-positive anti-T. gondii
IgM/IgG antibodies suggests the potential risk of parasite
transmission by blood transfusion practices.
Findings on the association of HIV and toxoplasmosis
seroprevalence are varied in different parts of the world.Previous studies involving HIV-infected individuals have
reported wide variations in T. gondii seroprevalence
(3%–22%) [38,39]. Some authors found higher preva-
lence of T. gondii specific IgG in HIV-infected patients
compared to non-infected individuals [40,41], whereas
others did not find any differences between the two
groups [42]. Serologic data provided little information,
in extracerebral toxoplasmosis in patients infected with
HIV [43]. Previous studies in Ethiopia revealed a higher
Toxoplasma seroprevalence in both HIV infected and
non-infected individuals that is not statistically signifi-
cantly different between the two groups [29]. On the
other hand, studies from Mozambique [44] found similar
higher toxoplasmosis occurrence in the HIV-positive
groups as compared to HIV-negative groups that
according to the authors could be ascribed to common
or associated risk factors for both infections, such as
exposure to both sexual contacts and meat consumption.
Several explanations for the interaction between both
infections resulting in high Toxoplasma infection in HIV
patients have been previously proposed [45]. One
possibility is an increase in risky behavior in Toxoplasma
infected individuals that leads to increased exposure to
HIV infection. Such a change in behavior could be due
to parasite-driven personality changes, as described in
Toxoplasma-infected individuals by others [46]. Another
plausible explanation is that Toxoplasma infection is a
marker of exposure to risky social contacts or habits,
which correlates with early HIV infection.
Regarding the higher prevalence in males than females,
Shimelis et al., [47] observed a statistically significantly
higher prevalence rate of Toxoplasma infection in males
than females in the bivariate analysis, which disappeared
in the multivariate analysis. In our case the difference is
maintained in the multivariate model and may be attributed
to differences in socialization behavior or environmental
exposure of males compared to females.
Conclusion
In conclusion, the present findings showed a high
seroprevalence of anti-T. gondii antibodies in HIV
infected pre-ART and HIV non-infected apparently
healthy blood donors in Bahir Dar. Consumption of
undercooked or raw meat and contact with cat might
greatly contribute towards acquiring T. gondii infection.
It may be appropriate to include a routine serological
screening test for determination anti-T. gondii antibodies
in HIV infected pre ART individuals and HIV negative
apparently healthy blood donors. Those HIV infected
individuals, positives for anti-T. gondii antibodies should
be considered for chemoprophylactic treatment. In
addition, health education particularly not to eat
undercooked and raw meat, and avoiding contact with
cats should be considered.
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